Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

Every second, an adult generates around five million new blood cells to replace aging or dying ones, making the blood system a highly regenerative organ.